Belrose Pharma, Inc.
Records under this name other than patents Belrose Pharma, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 7,122,189 | Releasable polymeric conjugates based on aliphatic biodegradable linkers Lapsed on the fee record Ended Oct 17, 2018 · From the USPTO record | Lapsed on the fee record | Ended Oct 17, 2018 | From the USPTO record |
| US 7,087,229 | Releasable polymeric conjugates based on aliphatic biodegradable linkers Lapsed on the fee record Ended Aug 8, 2018 · From the USPTO record | Lapsed on the fee record | Ended Aug 8, 2018 | From the USPTO record |
| US 7,723,351 | Multi-arm polymeric conjugates of 7-ethyl-10-hydroxycamptothecin for treatment of breast, colorectal, pancreatic, ovarian and lung cancers Lapsed on the fee record Ended May 25, 2018 · From the USPTO record | Lapsed on the fee record | Ended May 25, 2018 | From the USPTO record |
| US 7,671,067 | Treatment of non-hodgkin's lymphomas with multi-arm polymeric conjugates of 7-ethyl-10-hydroxycamtothecin Lapsed on the fee record Ended Mar 2, 2018 · From the USPTO record | Lapsed on the fee record | Ended Mar 2, 2018 | From the USPTO record |
| US 8,618,124 | Heterobifunctional polymeric bioconjugates Lapsed on the fee record Ended Dec 31, 2017 · From the USPTO record | Lapsed on the fee record | Ended Dec 31, 2017 | From the USPTO record |
| US 7,601,798 | Methods of preparing polymers having terminal amine groups using protected amine salts Lapsed on the fee record Ended Oct 13, 2017 · From the USPTO record | Lapsed on the fee record | Ended Oct 13, 2017 | From the USPTO record |
| US 7,595,304 | Polymeric oligonucleotide prodrugs Lapsed on the fee record Ended Sep 29, 2017 · From the USPTO record | Lapsed on the fee record | Ended Sep 29, 2017 | From the USPTO record |
| US 7,569,657 | Methods of preparing polymers having terminal amine groups using protected amine salts Lapsed on the fee record Ended Aug 4, 2017 · From the USPTO record | Lapsed on the fee record | Ended Aug 4, 2017 | From the USPTO record |
| US 8,367,065 | Targeted polymeric prodrugs containing multifunctional linkers Lapsed on the fee record Ended Feb 5, 2017 · From the USPTO record | Lapsed on the fee record | Ended Feb 5, 2017 | From the USPTO record |
| US 7,462,627 | Multi-arm polymeric conjugates of 7-ethyl-10-hydroxycamptothecin for treatment of breast, colorectal, pancreatic, ovarian and lung cancers Lapsed on the fee record Ended Dec 9, 2016 · From the USPTO record | Lapsed on the fee record | Ended Dec 9, 2016 | From the USPTO record |